FDA Alerts

FDA Alerts
FDA Alerts
FDA: Monitor Hep C Patients for Hep B Reactiviation
10/04/2016
The US Food and Drug Administration is now requiring a Boxed Warning be added to the drug labels of certain direct-acting antiviral medicines used for the treatment of hepatitis C.
10/04/2016
FDA
FDA
FDA Warns Against Use of Homeopathic Teething Tablets and Gels               
10/03/2016
The FDA issued a statement regarding serious adverse events with homeopathic teething tablets and gels.
10/03/2016
FDA Alerts
FDA Alerts
FDA Approves Artificial Pancreas
09/30/2016
The FDA approved a system to automatically monitor glucose and administer basal insulin doses in individuals aged 14 and older with type 1 diabetes.
09/30/2016
FDA Alerts
FDA Alerts
FDA Approves New Option for Crohn Disease
09/26/2016
The FDA approved a biologic to treat adults with active Crohn disease who have failed or were intolerant to treatment with immunomodulators or corticosteroids.
09/26/2016
FDA Alerts
FDA Alerts
FDA Approves Adalimumab Biosimilar
09/26/2016
The FDA approved the biosimilar adalimumab-atto for the treatment of inflammatory diseases including RA, psoriatic arthritis, and Crohn's disease.
09/26/2016
FDA Alerts
FDA Alerts
FDA Approves New Option for Type 2 Diabetes (INVOKAMET XR)
09/21/2016
The FDA has approved INVOKAMET XR for use as a supplement to diet and exercise for improved control of blood glucose levels in adults with type 2 diabetes.
09/21/2016
FDA Alerts
FDA Alerts
FDA Approves New Option for Secondary CV Prevention
09/15/2016
The FDA approved Yosprala to treat patients who need aspirin for secondary prevention of cardiovascular and cerebrovascular events.
09/15/2016
Medication Prescribing
Medication Prescribing
FDA Issues Strong Warnings Against Combining Opioids and Benzodiazepine
09/01/2016
The FDA is requiring boxed warnings for opioid analgesics and prescription opioid cough products related to combined use of certain opioids with benzodiazepines.
09/01/2016
FDA Alerts
FDA Alerts
FDA Approves Biosimilar for Various Inflammatory Diseases
08/31/2016
The FDA approved a biosimilar to treat RA, polyarticular juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis.
08/31/2016
FDA Alerts
FDA Alerts
FDA Approves New Quadrivalent Influenza Vaccine
08/30/2016
The FDA has approved Afluria Quadrivalent for the use in individuals 18 years and older for active immunization against influenza cause by influenza A and B viruses.
08/30/2016